Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1623

1.

Novel Targeted Agents in the Treatment of Multiple Myeloma.

Varga C, Laubach J, Hideshima T, Chauhan D, Anderson KC, Richardson PG.

Hematol Oncol Clin North Am. 2014 Oct;28(5):903-925. doi: 10.1016/j.hoc.2014.07.001. Epub 2014 Aug 5. Review.

PMID:
25212889
[PubMed - as supplied by publisher]
2.

Exercise training reverses endothelial dysfunction in non-alcoholic fatty liver disease.

Pugh CJ, Sprung VS, Kemp GJ, Richardson P, Shojaee-Moradie F, Umpleby AM, Green DJ, Cable NT, Jones H, Cuthbertson DJ.

Am J Physiol Heart Circ Physiol. 2014 Sep 5. pii: ajpheart.00306.2014. [Epub ahead of print]

PMID:
25193471
[PubMed - as supplied by publisher]
3.

Infectious Postoperative Complications Decrease Long-term Survival in Patients Undergoing Curative Surgery for Colorectal Cancer: A Study of 12,075 Patients.

Artinyan A, Orcutt ST, Anaya DA, Richardson P, Chen GJ, Berger DH.

Ann Surg. 2014 Sep 1. [Epub ahead of print]

PMID:
25185465
[PubMed - as supplied by publisher]
4.

Outdoor tobacco smoke exposure at the perimeter of a tobacco-free university.

Cho H, Lee K, Hwang Y, Richardson P, Bratset H, Teeters E, Record R, Riker C, Hahn EJ.

J Air Waste Manag Assoc. 2014 Aug;64(8):863-6.

PMID:
25185388
[PubMed - in process]
5.

Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data.

Husain N, Blais P, Kramer J, Kowalkowski M, Richardson P, El-Serag HB, Kanwal F.

Aliment Pharmacol Ther. 2014 Aug 26. doi: 10.1111/apt.12923. [Epub ahead of print]

PMID:
25155259
[PubMed - as supplied by publisher]
6.

Temporal Trends of Non-alcoholic Fatty Liver Disease-related Hepatocellular Carcinoma in the Veteran Affairs Population.

Mittal S, Sada YH, El-Serag HB, Kanwal F, Duan Z, Temple S, May SB, Kramer JR, Richardson PA, Davila JA.

Clin Gastroenterol Hepatol. 2014 Aug 19. pii: S1542-3565(14)01228-2. doi: 10.1016/j.cgh.2014.08.013. [Epub ahead of print]

PMID:
25148760
[PubMed - as supplied by publisher]
7.

The challenge of cross-trial comparisons using limited data.

Laubach JP, Faber EA Jr, Voorhees P, Moslehi J, Varga C, Niculescu L, Anderson KC, Richardson PG.

Haematologica. 2014 Aug;99(8):e145-6. doi: 10.3324/haematol.2013.103135. No abstract available.

PMID:
25082787
[PubMed - in process]
Free PMC Article
8.

Phytophthora ×stagnum nothosp. nov., a new hybrid from irrigation reservoirs at ornamental plant nurseries in Virginia.

Yang X, Richardson PA, Hong C.

PLoS One. 2014 Jul 29;9(7):e103450. doi: 10.1371/journal.pone.0103450. eCollection 2014.

PMID:
25072374
[PubMed - in process]
Free PMC Article
9.

PREDICT: a diagnostic accuracy study of a tool for predicting mortality within one year: Who should have an advance healthcare directive?

Richardson P, Greenslade J, Shanmugathasan S, Doucet K, Widdicombe N, Chu K, Brown A.

Palliat Med. 2014 Jul 25. pii: 0269216314540734. [Epub ahead of print]

PMID:
25062815
[PubMed - as supplied by publisher]
10.

Thermally Activated Delayed Fluorescence (TADF) and Enhancing Photoluminescence Quantum Yields of [CuI(diimine)(diphosphine)]+ Complexes-Photophysical, Structural, and Computational Studies.

Linfoot CL, Leitl MJ, Richardson P, Rausch AF, Chepelin O, White FJ, Yersin H, Robertson N.

Inorg Chem. 2014 Jul 23. [Epub ahead of print]

PMID:
25054425
[PubMed - as supplied by publisher]
11.

The sensitivity comparison of bar electrode and disposable ring electrode for recording of lateral femoral cutaneous nerve.

Burakgazi AZ, Russo M, Richardson PK.

Ann Indian Acad Neurol. 2014 Apr;17(2):179-81. doi: 10.4103/0972-2327.132621.

PMID:
25024568
[PubMed]
Free PMC Article
12.

Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand.

Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J, Celentano DD, Metzger D, Jackson JB, Burns D.

Drug Alcohol Depend. 2014 Sep 1;142:139-45. doi: 10.1016/j.drugalcdep.2014.06.013. Epub 2014 Jun 19.

PMID:
24999060
[PubMed - in process]
13.

Triple arthrodesis for adult acquired flatfoot.

Catanzariti AR, Dix BT, Richardson PE, Mendicino RW.

Clin Podiatr Med Surg. 2014 Jul;31(3):415-33. doi: 10.1016/j.cpm.2014.03.004. Review.

PMID:
24980931
[PubMed - in process]
14.

Unlocking the potential benefits of flow chemistry in the drug-discovery process.

Richardson P.

Future Med Chem. 2014 May;6(8):845-7. doi: 10.4155/fmc.14.49. No abstract available.

PMID:
24962275
[PubMed - in process]
15.

Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy.

Patel CG, Yee AJ, Scullen TA, Nemani N, Santo L, Richardson PG, Laubach JP, Ghobrial IM, Schlossman RL, Munshi NC, Anderson KC, Raje NS.

Clin Cancer Res. 2014 Aug 1;20(15):3955-61. doi: 10.1158/1078-0432.CCR-14-0434. Epub 2014 Jun 23.

PMID:
24958808
[PubMed - in process]
16.

Allogeneic transplantation in multiple myeloma: a potential renaissance in the era of novel therapies?

Richardson P.

Biol Blood Marrow Transplant. 2014 Aug;20(8):1078-9. doi: 10.1016/j.bbmt.2014.06.013. Epub 2014 Jun 21. No abstract available.

PMID:
24956499
[PubMed - in process]
17.

A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients.

Bae J, Prabhala R, Voskertchian A, Brown A, Maguire C, Richardson P, Dranoff G, Anderson KC, Munshi NC.

Leukemia. 2014 May 14. doi: 10.1038/leu.2014.159. [Epub ahead of print]

PMID:
24935722
[PubMed - as supplied by publisher]
18.

Selective and potent akt inhibition triggers anti-myeloma activities and enhances fatal endoplasmic reticulum stress induced by proteasome inhibition.

Mimura N, Hideshima T, Shimomura T, Suzuki R, Ohguchi H, Rizq O, Kikuchi S, Yoshida Y, Cottini F, Jakubikova J, Cirstea D, Gorgun G, Minami J, Tai YT, Richardson PG, Utsugi T, Iwama A, Anderson KC.

Cancer Res. 2014 Aug 15;74(16):4458-69. doi: 10.1158/0008-5472.CAN-13-3652. Epub 2014 Jun 16.

PMID:
24934808
[PubMed - in process]
19.

Update on proteasome inhibitors in multiple myeloma.

Richardson PG.

Clin Adv Hematol Oncol. 2014 Mar;12(3):179-81. No abstract available.

PMID:
24927266
[PubMed - in process]
20.

Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients.

Richardson PG, Baz R, Wang M, Jakubowiak AJ, Laubach JP, Harvey RD, Talpaz M, Berg D, Liu G, Yu J, Gupta N, Di Bacco A, Hui AM, Lonial S.

Blood. 2014 Aug 14;124(7):1038-46. doi: 10.1182/blood-2014-01-548826. Epub 2014 Jun 11.

PMID:
24920586
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk